Inizio Ignite

Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.
- Advertisement -

IMED leader one of 48 new fellows recognised for the advancement of medical science in the UK

Each year the Academy of Medical Sciences elect a small number of UK scientists to their Fellowship in recognition of their contribution to the advancement of medical science. Potential Academy Fellows are nominated for election based on their excellence in medical research, their innovative application of scientific knowledge or for their service to healthcare.

Earlier today, it was announced that Mene Pangalos, Executive Vice President of our Innovative Medicines and Early Development Biotech Unit, has been elected as one of just 48 new Fellows – out of more than 350 nominations.

On hearing the news, Mene commented: “It’s a great honour to be elected as a Fellow of the Academy of Medical Sciences. I am looking forward to working with the Fellowship to drive greater connections between academia, industry and the NHS and to develop new ways to inspire the next generation of UK scientists.”

 

Latest stories

Related stories

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data

Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »